Latest / The BioHub - by Avetix
Episode 222 - Frederic Sweeney - CEO VedaBio
Today I’m joined by Frédéric Sweeney, President and CEO of VedaBio.
Fred has spent his career at the intersection of healthcare, diagnostics, venture capital and company building. He’s also been involved with a number of companies as an investor, board member and advisor.
Today, Fred is leading VedaBio, which is developing a new approach to molecular diagnostics using CRISPR. The company’s technology is designed to deliver highly accurate molecular detection much faster and closer to the point of care, with the goal of making sophisticated molecular testing much more accessible.
I’m really…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.